<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<title>article149</title>
<style>
        body {
            font-family: Arial, sans-serif;
            margin: 0;
            padding: 0;
            background-color: #f3f3f3;
        }
        .container {
            max-width: 800px;
            margin: auto;
            background: #fff;
            padding: 20px;
            box-shadow: 0 0 10px rgba(0, 0, 0, 0.1);
        }
        h1, h2 {
            color: #333;
        }
        p {
            line-height: 1.6;
        }
        a {
            text-decoration: none;
            color: #5a5a5a;
        }
        a:hover {
            color: #000;
        }
    </style>
</head>
<body>
<div class="container"><p><a href="../index.html">Back to Index</a></p><li><a href="https://www.wikijournalclub.org/wiki/PRAMI" style="display:block; margin-bottom:10px;">PRAMI Original</a></li>
<h2><strong>PRAMI</strong></h2>
<div class="container">
<h2><strong></strong></h2>
<div class="container">
<div class="container">
<h2><strong></strong></h2>
<h2><strong></strong></h2>
<br/>
<br/>
<h2><strong>Clinical Question</strong></h2><br/>
Does performing preventive percutaneous coronary intervention (PCI) in noninfarct arteries during emergency myocardial infarction (MI) PCI reduce adverse cardiovascular events in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease?<br/>
<br/>
<h2><strong>Bottom Line</strong></h2><br/>
Preventive PCI in noninfarct arteries with significant stenosis during primary PCI for STEMI significantly reduces the risk of future adverse cardiovascular events compared to treating the infarct artery alone.<br/>
<br/>
<h2><strong>Major Points</strong></h2><br/><br/>
<br/>
<h2><strong>Guidelines</strong></h2><br/>
Current guidelines recommend PCI of the infarct artery only in STEMI patients with multivessel disease, owing to previous lack of evidence regarding the value of preventive PCI.<br/>
<br/>
<h2><strong>Design</strong></h2><br/><br/>
<br/>
<h2><strong>Population</strong></h2><br/>
The trial enrolled 465 patients with acute STEMI and multivessel coronary disease detected at the time of emergency PCI for the infarct artery. <br/>
<br/>
Inclusion Criteria:<br/>
- Acute STEMI, including three patients with left bundle-branch block<br/>
- Successful PCI treatment of the infarct artery<br/>
- Stenosis of â‰¥50% in other coronary arteries treatable by PCI<br/>
<br/>
Exclusion Criteria:<br/>
- Cardiogenic shock<br/>
- Previous coronary-artery bypass grafting<br/>
- Ineligibility due to other specified concerns<br/>
<br/>
<h2><strong>Interventions</strong></h2><br/>
Patients were randomized to receive either no further PCI procedures after the infarct-artery PCI (n=231) or to undergo immediate preventive PCI in noninfarct arteries with &gt;50% stenoses (n=234).<br/>
<br/>
<h2><strong>Outcomes</strong></h2><br/>
The primary outcome was a composite of death from cardiac causes, nonfatal myocardial infarction, or refractory angina.<br/>
<br/>
<h2><strong>Major Points</strong></h2><br/>
Primary outcomes occurred in 21 patients in the preventive-PCI group and 53 in the infarct-artery-only PCI group, revealing a significant hazard ratio of 0.35 in favor of preventive PCI. Hazard ratios for death from cardiac causes, nonfatal MI, and refractory angina were also in favor of preventive PCI. <br/>
<br/>
<h2><strong>Criticisms</strong></h2><br/>
The study did not address whether the benefits of preventive PCI extend to patients with non-STEMI or whether immediate or delayed (staged) preventive PCI is superior.<br/>
<br/>
<h2><strong>Funding</strong></h2><br/>
Supported by Barts and the London Charity.<br/>
<br/>
<h2><strong>Further Reading</strong></h2><br/>
The article was published on September 1, 2013, at NEJM.org.
    <p></p>
</div>
</div>
</div>
</div>
</body>
</html>
